Infectious Diseases

Accurate and reliable detection of infectious disease biomarkers plays a critical role in early diagnosis, disease management, and infection control. With the continuous emergence of new pathogens and evolving disease patterns, high-quality diagnostic solutions are essential for improving patient outcomes and supporting global health protection. Cnpair is dedicated to the development of high-quality infectious diseases raw materials, providing comprehensive antigen and antibody solutions for a wide range of pathogens.

antibody antigen

Infectious Diseases

Mycobacterium Tuberculosis

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs and remaining a major global health concern. TB testing is essential for early detection, clinical diagnosis, treatment monitoring, and infection control. Cnpair has introduced high-performance antibody pairs and antigens for TB detection including TB-IGRA, TB-LAM, etc., which demonstrating excellent sensitivity and specificity across CLIA, EIA, and LF platforms.

  • TB-IGRA
  • TB LAM
  • TB-Ab

Rotavirus

Rotavirus (RV) is a highly contagious virus and one of the leading causes of acute gastroenteritis, especially among infants and young children. RV infection can cause symptoms such as diarrhea, vomiting, fever, and dehydration, which may lead to severe illness in vulnerable populations. Cnpair RV antigen raw materials feature high sensitivity and specificity, optimized performance for fecal RV antigen detection, and excellent specificity with no cross-reactivity, supporting the development of reliable and accurate rotavirus diagnostic assays.

Enterovirus 71

Enterovirus 71 (EV71) is a major pathogen associated with hand, foot, and mouth disease (HFMD), especially in children. EV71 testing helps enable early diagnosis, disease surveillance, and prevention of severe complications. Cnpair EV71 IgM antibodies demonstrate clinically confirmed concordance, enabling precise capture of EV71-specific IgM and supporting early diagnosis of hand, foot, and mouth disease (HFMD) with reliable performance.

  • EV71

Helicobacter pylori

Helicobacter pylori (HP) is a spiral-shaped bacterium that colonizes the human stomach and is one of the most common chronic bacterial infections worldwide. HP infection can cause chronic gastritis, peptic ulcers, and is strongly associated with gastric cancer development. Cnpair offers a comprehensive portfolio of native antigens for antibody detection, quality control materials, and HP antibodies for fecal sample testing. With high activity and broad epitope coverage, our raw materials support reliable assay performance and help minimize missed detections.

  • Hp antigen
  • Hp Antibody
  • Anti Human IgG Antibody

Epstein-Barr Virus

Epstein-Barr Virus (EBV) is a widespread human herpesvirus associated with infectious mononucleosis and several malignancies. EBV testing is important for infection diagnosis, immune status assessment, and disease monitoring. Cnpair EBV antigen raw materials are designed with broad epitope coverage and excellent specificity, enabling reliable recognition of EBV-related targets. They support the development of high-performance immunoassays across multiple platforms, including CLIA, ELISA, and LF.

  • EBV EBNA1
  • EBV VCA
  • EBV Zta

Monkeypox Virus

Monkeypox Virus (MPV) is an emerging zoonotic virus belonging to the Orthopoxvirus genus. Human infection can cause mpox, a disease characterized by fever, skin lesions, and lymph node swelling. Cnpair MPV antigen raw materials identify highly immunogenic epitopes, including A29L and other novel targets, delivering excellent specificity and sensitivity with broad coverage across all monkeypox virus clades. They are compatible with multiple platforms, including CLIA, LF and ELISA.

  • Monkeypox

Related Posts

Raw Materials for Gastrointestinal Diseases Materials banner (1)
Cnpair Advances Early Raw Materials for Gastrointestinal Diseases
High-Purity-Native-Antigens-cnpair
Native Antigen – Ideal Choice for Reagent Development